{"nct_id":"NCT02397096","title":"Safety and Efficacy of a Switch to Doravirine, Tenofovir, Lamivudine (MK-1439A) in Human Immunodeficiency Virus (HIV-1)-Infected Participants Virologically Suppressed on an Anti-retroviral Regimen in Combination With Two Nucleoside Reverse Transcriptase Inhibitors (MK-1439A-024)","status":"COMPLETED","status_verified_date":"2024-11","start_date":"2015-06-09","start_date_type":"ACTUAL","primary_completion_date":"2018-02-22","primary_completion_date_type":"ACTUAL","completion_date":"2023-09-05","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["MRK"]}